{"id":"488745629660-19","name":"European Vaccine Initiative","registrationDate":"2018-01-17T17:43:57.102+02:00","category":3,"subCategory":2,"legal":"European Economic Interesting Group","web":"http://www.euvaccine.eu","country":"Germany","headAddress":"Voßstrasse 2","headCity":"Heidelberg","headPostCode":"69115","headPhone":"(49)62 21 56 65 24","boss":"Hilde Depraetere","bossTitle":"Ms","bossPosition":"Acting Executive Director","membersCount":2,"membersFTE":"0.5","membership":"","memberOrga":"Partners of the EEIG&#xd;\nsee http://www.euvaccine.eu/about-us/governance/board","goal":"The European Vaccine Initiative (EVI) is leading European efforts to develop effective, accessible, and affordable vaccines against diseases of poverty. EVI’s vision is 'a world free of the intolerable burden of diseases of poverty within the coming decades.&#xd;<br />EVI is contributing to the global efforts to control these diseases in three main ways:&#xd;<br />1. Creating an environment to accelerate the development and clinical assessment of vaccine candidates for diseases of poverty&#xd;<br />2. Promoting affordability and accessibility of vaccines for diseases of poverty in low income populations&#xd;<br />3.Seeking to align all major stakeholders and acting as a focal point to ensure the successful development of vaccines for diseases of poverty for low income populations.","acronym":"EVI","interests":"Public Health, Research and innovation","euInitiatives":"EVI is following  policies and laws of:&#xd;<br />EU directive on Clinical trials&#xd;<br />EUDRACT&#xd;<br />EUDRALEX&#xd;<br />European Medicine Agency&#xd;<br />Joint Research Center&#xd;<br />National Regulatory agencies","lastUp":"2019-09-06T14:53:10.747+02:00","customers":"","costAbsolu":"","costRange":"10000-24999","turnoverAbsolu":0,"turnoverRange":""}